Selexys Pharmaceuticals

Selexys develops novel therapeutics for the treatment of inflammatory and thrombotic diseases.

Business Model:

Revenue: $8.5M

Employees: 51-200

Rankings

Detailed Selexys Pharmaceuticals Information

Selexys Pharmaceuticals was acquired by Novartis.
The acquisition happend on 2016-11-21.
Details of the transaction were not public

Acquirer

Geographic Data

Selexys Pharmaceuticals headquarters map

Address: 840 Research Pkwy

City: Oklahoma City

State: OK

Zip: 73104

Country: US

Financial Info

Stage:

series b

Raised Last:

$43M

Raised Total:

$52M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Selexys develops novel therapeutics for the treatment of inflammatory and thrombotic diseases.

Contact Phone:
+14053198195

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
7/2009 Debt Financing $3.4M
11/2010 Debt $5M
1/2009 Seed Round 2 - i2E
Oklahoma Seed Capital Fund
i2E
Oklahoma Seed Capital Fund
9/2012 Series A 1 $23M MPM Capital
MPM Capital
9/2012 Series A $43.2M
8/2008 Debt $3.4M
11/2011 Debt Financing $5M
2/2015 Series B $43.2M
1/2009 Seed Round 2 - i2E
Oklahoma Seed Capital Fund
i2E
Oklahoma Seed Capital Fund
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research